Bovine Parainfluenza Virus Type 3 (BPI3V) infections are often asymptomatic, causing respiratory 25 tissue damage and immunosuppression, predisposing animals to severe bacterial pneumonia, the 26 leading cause of Bovine Respiratory Disease (BRD) mortality. As with many pathogens, routine 27 BPI3V serology does not indicate the presence of damaged respiratory tissue or active infection. In 28 vitro proteomic marker screening using disease relevant cell models could help identify markers of 29 infection and tissue damage that are also detectable during in vivo infections. This study utilised a 30 proteomic approach to investigate in vitro cellular responses during BPI3V infection to enhancing 31 the current understanding of intracellular host-virus interactions and identify putative markers of in 32 vivo infection. Through 2D gel electrophoresis proteomic analysis, BPI3V Phosphoprotein P and 33 host T-complex Protein 1 subunit theta were found to be accumulated at the latter stages of 34 infection within bovine fibroblasts. These proteins were subsequently detected using targeted 35 multiple reaction monitoring (MRM) mass spectrometry in the plasma of animals challenged with 36 BPI3V, with differential protein levels profile observed dependant on animal vaccination status. 37 Potential mechanisms by which BPI3V overcomes host cellular immune response mechanisms 38 allowing for replication and production of viral proteins were also revealed. Assessment of 39 circulating protein marker levels identified through an in vitro approach as described may enable 40 more effective diagnosis of active viral infection and diseased / damaged respiratory tissue in 41 animals and allow for more effective utilisation of preventative therapeutic interventions prior to 42 bacterial disease onset and significantly aid the management and control of BRD. 43 44 45 93 determine virus induced respiratory tract damage and enable early treatment measures to be 94 employed to prevent progression to more severe clinical disease states. 95 96 5 Materials and methods 97 Chemicals and reagents 98 GMEM, trypsin, gentamicin and glutamine were purchased from Invitrogen (Life Technologies, 99 Paisley, UK). Dithiothreitol (DTT), iodoacetamide (IAA), and Readysol IEF were purchased from 100 GE Healthcare (Buckinghamshire, UK). LC-MS grade formic acid, acetonitrile and H2O were 101 purchased from Fisher Scientific (MA, USA). All other reagents were electrophoresis grade and 102 purchased from Fisher Scientific. Sequencing grade modified trypsin was purchased from Promega 103 (WI, USA). 104 105 In vitro identification of candidate BPI3V protein biomarkers 106 Cell culture and virus preparation 107 Foetal Calf Lung (FCL) cells were prepared within the cell culture department of the Veterinary 108 Science Division at the Agri-Food and Biosciences Institute, Northern Ireland. Throughout this 109 study FCL cells were maintained at 37ºC, 5% CO2 and adapted to low serum conditions via 110 continuous passage in GMEM (supplemented with 1% glutamine, 0.1% gentamicin) with reducing 111 foetal calf serum (FCS) concentration. Following adaption, cell viability and integrity was assessed 112 by Alamar Blue (Invitrogen) and lactose dehydrogenase (LDH) (Roche, Basel, Switzerland) 113 cytotoxicity assays using manufacturer's protocols. 114 115 Preparation of samples for in vitro biomarker screening 116 FCL cells were seeded at a density of 6.25x10 5 cells per ml in 375ml culture flasks. Cells were 117 grown for 4 days until monolayered, then infected with BPI3V (isolate 2005/015033-Lung A -118 propagated in FCL cells (TCID50 10 8.2 /ml)) a m.o.i. of 10:1 and incubated for 1hr. Media was 119 removed and cells washed 3 times with GMEM containing no FCS which was removed and 120 replaced with GMEM containing 0.5% FCS. Lysates were prepared from BPI3V infected FCL 121 flasks at 24hrs and 48hrs (n=6) post-infection (p.i.). 27hrs prior to sample collection, media was 122 6 removed and cells washed 3 times over a period of 3hrs with GMEM containing no FCS. Then 123 washing media was removed and replaced with GMEM continuing no supplements. After 24hrs 124 culture media was removed from flasks and FCL monolayers washed twice with PBS and 1ml of 125 Lysis buffer (7M Urea, 2M Thiourea, 4% CHAPS, Roche Protease Inhibitor (1 tablets per 10ml 126 buffer) (Roche Applied Science, Lewes, East Sussex, United Kingdom) added and incubated for 127 15min to facilitate cell lysis prior to protein concentration determination. Lysates were similarly 128 prepared from uninfected cells (0hrs, n=6) as control. 129 130 2D Gel Electrophoresis and image acquisition 131 Cellular lysates were concentrated and desalted using 10kDa MW cut-off devices (Millipore, MA, 132 USA) and 500µg of each sample was dissolved in rehydration buffer (final concentration 8M Urea, 133
Introduction
Bovine Respiratory Disease (BRD) is a multifactorial disease characteristic of a viral-bacterial synergistic infection with predisposition from environmental stressors. The disease constitutes a 48 major source of economic loss through mortality, clinical disease and associated treatments with 49 long lasting reduced growth performance of infected young stock (Griffin, 1997) . Bovine 50 Parainfluenza Virus-3 (BPI3V) is one of the major viral pathogens of the BRD complex (Kahrs, 51 2001). BPI3V induced respiratory tract damage, resulting from the destruction of the ciliated 52 respiratory epithelium (Bryson, 1985) and immunosuppression via depression of local cellular 53 immunity by impairment of alveolar macrophage phagocytosis (Baker et al., 1997 , Trigo et al., 54 1985 , predisposes animals to more severe secondary bacterial and mycoplasma infections (Cusack 55 et al., 2003, Kapil and Basaraba, 1997) . With the absence of severe clinical symptoms (Vaucher et 56 al., 2008) , infected animals may not be detected prior to the onset of more severe infections 57 (AFBI/DAFM, 2012) . Furthermore, routinely employed BPI3V-antibody ELISA cannot 58 differentiate between vaccinated and infected animals, and by the time infected animals convalesce 59 the virus has been cleared from the system and respiratory tract damage has already occurred. 60 Molecular diagnostic techniques are hindered by the presence of vaccine derived genetic material, 61 often requiring on-going virus amplification in order to generate sufficient genetic material for 62 accurate diagnosis. Consequently, there are no commercial tests available for differentiation 63 between BPI3V vaccinated and non-vaccinated animals. Anti-mortem diagnostic tests for BPI3V 64 such as immunohistochemistry and virus isolation provide limited information on the current health 65 status of an animal and can only determine pathogen exposure but not the presence of diseased 66 tissue (Fulton and Confer, 2012) , further illustrating the need for the development of alternative 67 diagnostics capable of detecting infected animals (and the presence of diseased tissue) at early 68 stages of infection. 69 The development of biomarker based diagnostic tests relies on the detection of disease 70 markers accumulated/released from localised tissues regions in circulating bio-fluids. Primary cell 71 cultures offer a clean system that closely resembles relative tissue types for the identification of 72 high confidence candidate markers for in vivo diagnostics. With the death of BPI3V infected cells, 73 proteins are released into the extracellular space and ultimately into circulating bio-fluids. The 74 detection of such markers would indicate not only the presence of viral infection but also damaged 75 respiratory tissue, an indicator of underlying disease. Suitable primary cell models to investigate 76 BPI3V associated tissue damage include epithelial cells (the initial site of infection) and fibroblasts 77 (the major component of lung interstitium and likely secondary site of infection following BPI3V 78 release from epithelial cells). Whilst epithelial cells are the most promising cell types for candidate 79 biomarker screening previous studies on Human Parainfluenza Virus-3 (hPIV-3) and the closely 80 related paramyxovirus Respiratory Syncytial Virus (RSV) in A549 adenocarcinomic human 81 alveolar basal epithelial cells have indicated an apoptotic response to infection, with an arrest in 82 protein production (van Diepen et al., 2010 , Brasier et al., 2004 . Such condidtions are 83 unfavourable for biomarker screening which relies on the accumulation of disease specific markers 84 within tissues and their eventual release into circulating biofluids. Foetal Calf Lung (FCL) cells are 85 known to facilitate in vitro growth of BPI3V (Shephard et al., 2003) and may provide conditions 86 favourable for viral replication without shut down of host protein production, however little is 87 understood about the interactions of BPI3V with respiratory fibroblasts at the intracellular level. 88 Therefore, this study has set out to assess the proteomic responses of FCL cells during an in vitro 89 BPI3V infection by 2 Dimensional Gel Electrophoresis (2D GE) profiling, and to determine 90 whether identified candidate protein markers of in vitro infection can also be observed within the 91 plasma of animals following in vivo infection. Such markers released from infected cells or diseased 92 tissue, could be utilised to not only diagnose animals exposed to the viral pathogens but also images from analysis of pooled samples were used as a reference for warping and spot matching -141 approximately 20 manual warping anchors were applied to all gels prior to automatic alignment. 142 Spot borders and locations were manually refined to ensure accurate location and matching prior to 143 spot selection.
145
Mass-spectrometry analysis of protein gel spots 146 Gel spots were excised using a Gelpal spot cutter (Genetix) from pooled FCL lysates (comprised of 147 an equal amount of all samples, n=3) and in gel digestion was performed using modifications to a 7 previously described protocol (Shevchenko et al., 2006) Inter-channel and inter-scan delay were maintained at 0.005s, scan range at 0.5Da, and dwell at 213 0.025s for all peptides. tailed t-test. TargetLynx was used for the extraction of raw data and analysis. Integration 227 parameters were: retention time window 0.2 min, mean smoothing, width 3, 3 iterations, automatic 228 apex peak tracking and integration window extend of 5. Peak area values for the respective 229 peptides were corrected using the peak area of internal trypsin self-digestion products and spiked 230 yeast ADH was employed to assess peptide recovery. ADH standards in the range of 100µM to 231 10nM facilitated the relative quantification of protein levels in plasma. 254 The identity and sequence coverage of the 57 spots analysed by LC-MS are illustrated in Table 1 . 255 The estimated MW and pI of selected spots were determined by matching against a reference gel 256 map for MRC-5 fibroblasts (Rubporn et al., 2009 ). Data analysis was performed using Peaks 257 Studio (version 6) and 53 of 57 spots submitted for LC-MS were identified against a combined 258 Uniprot KB Bos taurus and BPI3V database. Blast searching revealed at least 1 unique peptide 259 sequence per protein, with average sequence coverage of 26.5% (ranging from 1-89%). These 260 annotations correspond to 35 unique proteins with a number of protein isomers detected as indicated 261 by varying estimated pI (Table 2) . Surprisingly, the only BPI3V related protein significantly altered 262 was Phosphoprotein P (9 isomers with isoelectric points ranging from pI 5.2 to 5.9). However, 263 other BPI3V proteins may have be present but did not pass marker selection criteria (FC > 1.5, p < 264 0.05 and high spot volume for MS/MS) or were poorly resolved membrane proteins 265 (haemagglutinin neuraminidase and fusion glycoprotein) a known limitation of 2D GE. This 266 protein was observed to be the second most abundant protein within cells at 48hrs p.i. (Figure 1) , 267 with only actin having a slightly higher spot volume. Furthermore, gel spots corresponding to T-268 complex proteins 1 subunit theta and 14-3-3 protein were significantly up-regulated in BPI3V 269 infected cells during the latter stages of infection (48hrs p.i.) with high intracellular abundance 270 ( Figure 1D ). There was a significant (p<0.001) correlation between the estimated and database 271 protein pI (R 2 = 0.9887) and MW (R 2 = 0.875) values for spots characterised by LC-MS, 272 confirming reliability in the identities conferred on selected proteins. no peptides corresponding to 14-3-3 protein beta/alpha were detectable in plasma at any time point.
LC-MS identification of differentially expressed protein spots
Unique peptides for phosphoprotein P and T-complex protein 1 subunit theta were found to be 331 significantly (p<0.05) up-regulated at day 5 p.i. in non-vaccinated animals compared to vaccinated 332 animals at the same stage as illustrated in Figure 3 . Plasma levels of Phosphoprotein P ( Figure 3A ) 333 were found to increase significantly (p<0.05) from day 1 to day 5 post-BPI3V challenge in non-334 vaccinated animals. 
Discussion
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